These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25341712)

  • 1. "They've gone about as far as they can go".
    King SB
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1202-3. PubMed ID: 25341712
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.
    Bozzani A; Ferlini M; Rossini R; Musumeci G; Arici V; Bramucci E; Setacci C
    J Cardiovasc Surg (Torino); 2015 Aug; 56(4):681-3. PubMed ID: 25008060
    [No Abstract]   [Full Text] [Related]  

  • 3. Stent thrombosis: a clinical perspective.
    Claessen BE; Henriques JP; Jaffer FA; Mehran R; Piek JJ; Dangas GD
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1081-92. PubMed ID: 25341705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revascularization in 2017: Technical and diagnostic improvements in PCI: more pieces in the puzzle.
    Colombo A; Mangieri A
    Nat Rev Cardiol; 2018 Feb; 15(2):80-82. PubMed ID: 29238060
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds.
    Gori T; Schulz E; Münzel T
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1194-5. PubMed ID: 25240537
    [No Abstract]   [Full Text] [Related]  

  • 6. Kounis syndrome manifesting as coronary aneurysm and very late coronary stent thrombosis.
    Hoshi T; Sato A; Akiyama D; Kawabe M; Hiraya D; Aonuma K
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e173-6. PubMed ID: 25459048
    [No Abstract]   [Full Text] [Related]  

  • 7. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
    Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
    Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
    Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
    Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY
    Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).
    Chen SL; Sheiban I; Xu B; Jepson N; Paiboon C; Zhang JJ; Ye F; Sansoto T; Kwan TW; Lee M; Han YL; Lv SZ; Wen SY; Zhang Q; Wang HC; Jiang TM; Wang Y; Chen LL; Tian NL; Cao F; Qiu CG; Zhang YJ; Leon MB
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1266-76. PubMed ID: 25326748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R; Rossini R; Musumeci G; Gadda F; Pozzo LF
    Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To stent or not to stent: the President Bush stent controversy.
    Waksman R
    Cardiovasc Revasc Med; 2013; 14(5):251-2. PubMed ID: 24034861
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of bioresorbable vascular scaffolds: niche or workhorse devices?
    Lahoud R; Ellis S
    Coron Artery Dis; 2017 Sep; 28(6):449-451. PubMed ID: 28644214
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute closure after stenting: not always a thrombus.
    Badr S; Dvir D; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):765-7. PubMed ID: 23239619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.